Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humana (NY: HUM )

288.12 +0.36 (+0.13%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
36 37 Next >
Five Ways to Make the Most of Your Prescription Drug Plan
(TJ Gibb, VP, Medicare Part D, Humana) - While inflation is forcing many people to cut back on purchases, spending on your health is not where you want to trim your budget. However, if you have a... 
Via NewsUSA
Topics Economy
Exposures Interest Rates
Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations
From Humana Inc.
Via Business Wire
For Second Time, Humana Kentucky Medicare Advantage HMO Plan Achieves Prestigious 5-Star Rating
From Humana Inc.
Via Business Wire
Shares of Humana Inc. (HUM) Rise Above Previous 52-Week High
Via Investor Brand Network
Humana Inc. (NYSE: HUM) Records 52-Week High Tuesday Morning
Via Investor Brand Network
8 Analysts Have This to Say About Humana
Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
For Third Time, Humana Tennessee Medicare Advantage HMO Attains Medicare’s Highest Rating for 2023
From Humana Inc.
Via Business Wire
Humana Louisiana Medicare Advantage Plan Receives Highest Possible Rating for Two Years in a Row
From Humana Inc.
Via Business Wire
96% of Humana’s Medicare Advantage Members are in Contracts rated 4-Star or Above for 2023; 66% are in Contracts Rated 4.5-Star or Higher
From Humana Inc.
Via Business Wire
Here’s What a Strong US Dollar Means for Your Stocks
The headlines pointing out the strong U.S. dollar is becoming commonplace these days. A strong U.S. dollar may be good for U.S. citizens buying foreign 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Humana Inc. to Release Third Quarter 2022 Results on November 2, 2022
From Humana Inc.
Via Business Wire
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members
From Humana Inc.
Via Business Wire
MarketBeat: Week in Review 9/26 – 9/30
As we close the worst September for stocks since 2008, our analysts continue to give you insight into the stocks and stories that are moving the market 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Humana Foundation Donates $1 Million to Support Disaster Recovery in the Wake of Hurricanes Ian and Fiona
From Humana Inc.
Via Business Wire
Humana Proves Vertically Integrated Healthcare Works
Health insurance and wellness provider Humana (NYSE: HUM) stock has been outperforming the benchmark indexes trading up 4.6% for the year 
Via MarketBeat
Topics Economy
Exposures Economy Labor
Looking Into Humana's Recent Short Interest
Humana's (NYSE:HUM) short percent of float has risen 4.76% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 1.32% of all regular shares that are... 
Via Benzinga
Humana Receives High Rankings in the Hispanic Association on Corporate Responsibility’s Corporate Inclusion Index
From Humana Inc.
Via Business Wire
Can HCA Healthcare Weather the Normalization?
Hospital and healthcare facilities operator HCA Healthcare (NYSE: HCA) stock has fallen (-25%) this year underperforming the payors. 
Via MarketBeat
Topics Bankruptcy Economy
Exposures COVID-19 Economy Financial
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $37,000 Today
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.98% on an annualized basis producing an average annual return of 19.75%. Currently, Humana has a market capitalization of... 
Via Benzinga
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
Eli Lilly leads medical stocks setting up and showing relative strength. 
Via Investor's Business Daily
CANO Stock Moves as Humana, CVS Consider Acquisition
Cano Health (CANO) stock is moving on Friday from reports that Humana (HUM) and CVS (CVS) are considering buying the company. 
Via InvestorPlace
Top Financial Media Stories Friday, September 23: Apple Resolves iPhone 14 Pro Camera Glitch, Credit Suisse Shares Tumble As It Looks For Capital Infusion, Boeing Penalized $200M For Misleading About 737 MAX Safety And More..
Reuters 
Via Benzinga
Humana, CVS Health Interested In Acquiring Primary Care Provider
U.S. 
Via Benzinga
Invest Like A Hedge Funder: This Activist Sent Wix Soaring, Here Are 2 Dividend Stocks He Owns
In October 2014, Starboard Value CEO and co-founder Jeffrey Smith made headlines for taking over Darden Restaurants (NYSE: DRI) by clearing the board and making himself the chairman with an 8.8% stake... 
Via Benzinga
RBC Capital Maintains Outperform Rating for Humana: Here's What You Need To Know
RBC Capital has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $541.00 to $544.00. Shares of Humana are trading up 0.97% over the last 24 hours, at... 
Via Benzinga
Morgan Stanley Upgrades Humana: Here's What You Need To Know
Morgan Stanley upgraded its rating of Humana (NYSE:HUM) to Overweight with a price target of $549.00, changing its price target from $494.00 to $549.00. Shares of Humana are trading up 0.97% over the... 
Via Benzinga
Why This Bullish Humana Analyst Just Raised His Price Target To $549 On The Stock
Checks suggest Humana Inc (NYSE: HUM) has improved its competitive positioning, which could lead to stronger membership growth in 2023, according to Morgan Stanley. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
Upgrades 
Via Benzinga
Keybanc Slashes PT On This Stock By 50%, Plus This Analyst Predicts $100 For PayPal
Susquehanna lowered the price target for PayPal Holdings, Inc. (NASDAQ: PYPL) from $115 to $100. PayPal shares fell 2.4% to $92.73 in pre-market trading. 
Via Benzinga
Oppenheimer Maintains Outperform Rating for Humana: Here's What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Humana (NYSE:HUM) and raise its price target from $520.00 to $550.00. Shares of Humana are trading down 0.25% over the last 24 hours, at... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.